1. Nonalcoholic steatohepatitis is the fastest growing cause of hepatocellular carcinoma in liver transplant candidates
- Author
-
Younossi, Zobair, Stepanova, Maria, Ong, Janus P., Ríos, María Belén, Mufari, Romina, Jacobson, Ira M., Bugianesi, Elisabetta, Duseja, Ajay, Eguchi, Yuichiro, Wong, Vincent W., Negro, Francesco, Yilmaz, Yusuf, Romero-Gómez, Manuel, George, Jacob, Ahmed, Aijaz, Wong, Robert, Younossi, Issah, Ziayee, Mariam, Afendy, Arian, Gilead Sciences, Younossi, Zobair, Stepanova, Maria, Ong, Janus P., Jacobson, Ira M., Bugianesi, Elisabetta, Duseja, Ajay, Eguchi, Yuichiro, Wong, Vincent W., Negro, Francesco, Yilmaz, H. Yusuf, Romero-Gomez, Manuel, George, Jacob, Ahmed, Aijaz, Wong, Robert, Younossi, Issah, Ziayee, Mariam, and Afendy, Arian
- Subjects
Male ,Alcoholic liver disease ,UNOSOPTN ,medicine.medical_treatment ,Liver transplantation ,ddc:616.07 ,Chronic liver disease ,Gastroenterology ,DISEASE ,Cohort Studies ,0302 clinical medicine ,OPTN ,Liver Cirrhosis, Alcoholic ,Non-alcoholic Fatty Liver Disease ,Nonalcoholic fatty liver disease ,Prevalence ,GLOBAL EPIDEMIOLOGY ,RISK ,ddc:616 ,Liver Cancer ,Mortality ,NAFLD ,Transplant Waitlist ,UNOS ,Hepatology ,Liver Neoplasms ,FATTY LIVER ,ASSOCIATION ,Hepatitis B ,Middle Aged ,CANCER ,030220 oncology & carcinogenesis ,Hepatocellular carcinoma ,030211 gastroenterology & hepatology ,Female ,Liver cancer ,Adult ,medicine.medical_specialty ,Carcinoma, Hepatocellular ,Adolescent ,UNITED-STATES ,NASH-CIRRHOSIS ,03 medical and health sciences ,Young Adult ,Hepatitis B, Chronic ,Internal medicine ,Diabetes mellitus ,medicine ,Humans ,neoplasms ,Aged ,business.industry ,Hepatitis C, Chronic ,medicine.disease ,CRYPTOGENIC CIRRHOSIS ,United States ,digestive system diseases ,Transplant waitlist ,business - Abstract
On Behalf of theGlobal Nonalcoholic Steatohepatitis Council., [Background and Aims] Although hepatitis B and C have been the main drivers of hepatocellular carcinoma (HCC), nonalcoholic steatohepatitis (NASH) has recently become an important cause of HCC. The aim of this study was to assess the causes of HCC among liver transplant (LT) candidates in the United States., [Methods] The Scientific Registry of Transplant Recipients (2002–2016) was used to estimate the trends in prevalence of HCC in LT candidates with the most common types of chronic liver disease: alcoholic liver disease (ALD), chronic hepatitis B (CHB), chronic hepatitis C, and NASH., [Results] 158,347 adult LT candidates were included. Of these, 26,121 (16.5%) had HCC; this proportion increased from 6.4% (2002) to 23.0% (2016) (trend P < .0001). Over the study period, CHC remained the most common etiology for HCC (65%). The proportions of HCC accounted for by CHC and ALD remained stable (both trend P > .10), the proportion of CHB decreased 3.1-fold (P < .0001), while the proportion of NASH in HCC increased 7.7-fold (from 2.1% to 16.2%; P < .0001). Furthermore, since 2002, the prevalence of HCC in LT candidates with NASH increased 11.8-fold, while this rate increased 6.0-fold in CHB, 3.4-fold in ALD, and 2.3-fold in CHC (all P < .0001); the increasing trend in NASH was steeper than that for any other etiology (P < .0001 in a trend regression model). The proportion of LT candidates with HCC who ultimately received a transplant or died while waiting did not differ between etiologies (P > .05)., [Conclusions] Nonalcoholic steatohepatitis is the most rapidly growing cause of HCC among US patients listed for liver transplantation., Ira M. Jacobson, Elisabetta Bugianesi, Vincent W. Wong, Manuel Romero-Gomez, and Aijaz Ahmed have received research funds and/or consultant fees from Gilead Sciences and Intercept Pharmaceuticals.
- Published
- 2019